Metraipolis › archive › dc_648748301f2d

Indoleamine 2,3-dioxygenase 1 in cancer immunotherapy: from small-molecule inhibition to PROTAC-mediated degradation — Europe PMC PMID:40894232

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40894232
DOI
10.3389/fphar.2025.1640073
License (as archived)
solo-consultazione
Archived
2026-11-10T17:28:19.984Z
SHA-256 of the archived text
8675703c0001bc141cfddba22cfc03701071a0c4818ca3c55cd7ad3d532319a9
Stable URL of this page
https://metraipolis.com/documento/dc_648748301f2d

How to cite

Indoleamine 2,3-dioxygenase 1 in cancer immunotherapy: from small-molecule inhibition to PROTAC-mediated degradation — Europe PMC PMID:40894232 — Europe PMC (en), https://europepmc.org/article/MED/40894232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_648748301f2d (Metraipolis archive dc_648748301f2d, sha256 8675703c0001bc141cfddba22cfc03701071a0c4818ca3c55cd7ad3d532319a9)
BibTeX
@misc{dc648748301f2d,
  title = {Indoleamine 2,3-dioxygenase 1 in cancer immunotherapy: from small-molecule inhibition to PROTAC-mediated degradation — Europe PMC PMID:40894232},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40894232},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_648748301f2d; sha256 8675703c0001bc141cfddba22cfc03701071a0c4818ca3c55cd7ad3d532319a9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40894232. Agents can read the archived copy with the MCP tool read_document.